Home
/
MONTE ROSA THERAPEUTICS, INC. (GLUE)
MONTE ROSA THERAPEUTICS, INC. (GLUE) Technical Analysis
Updated: 2026-03-17 00:36 UTC · Last close: 16.35 (+2.06%)
MONTE ROSA THERAPEUTICS, INC. (GLUE) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
MONTE ROSA THERAPEUTICS, INC. (GLUE) finished the session at 16.35 (+2.06%). Price has slipped under the 50-day average but remains above the 200-day average, leaving the longer-term structure intact even as medium-term momentum softens. 20-day momentum is notably weak at -8.76%; price remains inside its roughly 52-week range (3.70–25.31); and ATR14 volatility is elevated at roughly 7.24% of price. RSI(14) stands around 36.1, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging Cup & handle. The most important nearby levels are support at 13.47 and resistance at 18.30. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: 7.51M. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
Fundamentals Snapshot
Source: sec
Company
MONTE ROSA THERAPEUTICS, INC.
Note: This is an algorithmic technical snapshot (not financial advice).